Wilson Sonsini Goodrich & Rosati advised Terray on the transaction. Terray Therapeutics (Terray), a biotechnology company, announced raising $120 million in Series B funding round. The...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here